- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Acino Holding AG (ACIN)
| Open: | 95.00 | Day's Range: | 92.80 - 95.05 | Volume: | 8,406 |
|---|---|---|---|---|---|
| Previous Close: | 95.00 | 52wk Range: | 90.45 - 119.50 | 1-Yr Rtn: | -9.78% |
Key Statistics for ACIN
| Current P/E Ratio (ttm) | 53.4540 |
|---|---|
| Estimated P/E(12/2013) | 16.8309 |
| Relative P/E vs. SMI | 2.5645 |
| Earnings Per Share (EUR) (ttm) | 1.4200 |
| Est. EPS (EUR) (12/2013) | 4.5100 |
| Est. PEG Ratio | 0.4715 |
| Market Cap (M CHF) | 328.70 |
| Shares Outstanding (M) | 3.46 |
| 30 Day Average Volume | 4,913 |
| Price/Book (mrq) | 0.9511 |
| Price/Sale (ttm) | 1.8889 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (CHF) | - |
| Last Dividend | 04/11/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ACIN
No data available
Company Profile & Key Executives for ACIN
Acino Holding AG offers development, registration and manufacturing of generic and innovative pharmaceuticals using drug delivery technologies for which Acino also holds patents.
| Peter BuremaCEO/Member-Mgmt Board | Walter SaladinChief Financial Officer |
| Ruud Van AnraatChief Commercial Officer | Ulf Hergen WestphalHead:Quality/Member-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ACIN News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page